Media coverage
1Media coverage
Title VBL Therapeutics To Present Complete Phase 2 Data On VB-111 In Combination With Bevacizumab In Recurrent GBM At The Media name/outlet BioSpace Country United States Date 9/18/15 Persons Andrew Brenner
Press/Media: Press / Media
Media coverage
Title | VBL Therapeutics To Present Complete Phase 2 Data On VB-111 In Combination With Bevacizumab In Recurrent GBM At The |
---|---|
Media name/outlet | BioSpace |
Country | United States |
Date | 9/18/15 |
Persons | Andrew Brenner |